Corient IA LLC Acquires New Shares in Mettler-Toledo International, Inc. $MTD

Key Points

• Corient IA LLC has acquired a new position in Mettler-Toledo International by purchasing 250 shares valued at approximately $295,000.
• Insider transactions show significant sales, with directors selling a combined total of 2,424 shares worth nearly $3 million in the past three months.
• Analysts have mixed views on Mettler-Toledo, with a consensus target price of $1,288.89; multiple downgrades and price adjustments have been noted from various financial institutions.

Corient IA LLC purchased a new stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 250 shares of the medical instruments supplier's stock, valued at approximately $295,000.

Other hedge funds have also recently bought and sold shares of the company. Farther Finance Advisors LLC boosted its position in Mettler-Toledo International by 39.1% in the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock valued at $103,000 after buying an additional 25 shares during the last quarter. QRG Capital Management Inc. lifted its holdings in Mettler-Toledo International by 29.4% during the first quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock worth $577,000 after acquiring an additional 111 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Mettler-Toledo International by 13.3% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier's stock worth $2,929,000 after acquiring an additional 292 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in Mettler-Toledo International by 95.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock worth $2,600,000 after acquiring an additional 1,073 shares in the last quarter. Finally, Boston Trust Walden Corp lifted its holdings in shares of Mettler-Toledo International by 7.1% in the first quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier's stock valued at $40,871,000 after purchasing an additional 2,296 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Stock Up 3.3%

MTD traded up $42.4310 during trading on Friday, reaching $1,320.4310. 114,616 shares of the stock traded hands, compared to its average volume of 173,708. The stock has a market capitalization of $27.20 billion, a PE ratio of 33.44, a P/E/G ratio of 3.95 and a beta of 1.34. The stock's 50-day moving average is $1,224.30 and its 200 day moving average is $1,189.23. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. During the same quarter last year, the firm earned $9.65 EPS. The firm's revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Insider Activity

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the sale, the director owned 120 shares in the company, valued at approximately $139,191.60. This trade represents a 89.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Gerry Keller sold 165 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the sale, the insider owned 94 shares of the company's stock, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 2,889 shares of company stock worth $3,603,054. Corporate insiders own 1.94% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on MTD shares. Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their price target for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Evercore ISI cut their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research note on Monday, August 4th. Wells Fargo & Company upped their price target on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a report on Monday, May 5th. Wall Street Zen downgraded shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. Finally, Robert W. Baird increased their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, Mettler-Toledo International has a consensus rating of "Moderate Buy" and a consensus price target of $1,311.11.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.